Chiara Mussi

Chiara Mussi


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MBMarco Bertolotti
Marco Bertolotti
Amedeo LonardoAmedeo Lonardo
Amedeo Lonardo
CMChiara Mussi
Chiara Mussi
EBEnrica Baldelli
Enrica Baldelli
EPElisa Pellegrini
Elisa Pellegrini
PLPaola Loria
Paola Loria
Nonalcoholic fatty liver disease (NAFLD) is common in the elderly, in whom it carries a more substantial burden of hepatic (nonalcoholic steatohepatitis, cirrhosis and hepatocellular carcinoma) and extra-hepatic manifestations and complications (cardiovascular disease, extrahepatic neoplasms) than in younger age groups. Therefore, proper identification and management of this condition is a major task for clinical geriatricians and geriatric hepatologists. In this paper, the epidemiology and pathophysiology of this condition are reviewed, and a full discussion of the link between NAFLD and the aspects that are peculiar to elderly individuals is provided; these aspects include frailty, multimorbidity, polypharmacy and dementia. The proper treatment strategy will have to consider the peculiarities of geriatric patients, so a multidisciplinary approach is mandatory. Non-pharmacological treatment (diet and physical exercise) has to be tailored individually considering the physical limitations of most elderly people and the need for an adequate caloric supply. Similarly, the choice of drug treatment must carefully balance the benefits and risks in terms of adverse events and pharmacological interactions in the common context of both multiple health conditions and polypharmacy. In conclusion, further epidemiological and pathophysiological insight is warranted. More accurate understanding of the molecular mechanisms of geriatric NAFLD will help in identifying the most appropriate diagnostic and therapeutic approach for individual elderly patients.

1 January 2003 in Annals of Human Biology
Verified
Journal Article
Open access
MMM. Malavolti
M. Malavolti
CMChiara Mussi
Chiara Mussi
MPM. Poli
M. Poli
AFA. L. Fantuzzi
A. L. Fantuzzi
GSG. Salvioli
G. Salvioli
GBGiorgio Bedogni
Giorgio Bedogni
To calibrate eight-polar bioelectrical impedance analysis (BIA) against dual-energy X-ray absorptiometry (DXA) for the assessment of total and appendicular body composition in healthy adults. A cross-sectional study was carried out. Sixty-eight females and 42 males aged 21-82 years participated in the study. Whole-body fat-free mass (FFM) and appendicular lean tissue mass (LTM) were measured by DXA; resistance (R) of arms, trunk and legs was measured by eight-polar BIA at frequencies of 5, 50, 250 and 500 kHz; whole-body resistance was calculated as the sum R of arms, trunk and legs. The resistance index (RI), i.e. the height(2)/resistance ratio, was the best predictor of FFM and appendicular LTM. As compared with weight (Wt), RI at 500 kHz explained 35% more variance of FFM (vs 0.57), 45% more variance of LTM(arm) (vs 0.48) and 36% more variance of LTM(leg) (vs 0.50) (p < 0.0001 for all). The contribution of age to the unexplained variance of FFM and appendicular LTM was nil or negligible and the RI x sex interactions were either not significant or not important on practical grounds. The percent root mean square error of the estimate was 6% for FFM and 8% for LTM(arm) and LTM(leg). Eight-polar BIA offers accurate estimates of total and appendicular body composition. The attractive hypothesis that eight-polar BIA is influenced minimally by age and sex should be tested on larger samples including younger individuals.

4 November 2005 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MBMichele Brignole
Michele Brignole
CMCarlo Menozzi
Carlo Menozzi
ABAngelo Bartoletti
Angelo Bartoletti
FGFranco Giada
Franco Giada
ALAlfonso Lagi
Alfonso Lagi
ASAlessandro Scivales
Alessandro Scivales
Aims The guidelines of the European Society of Cardiology (ESC) define the current standard for the management of syncope, but are still incompletely applied in the clinical setting. Methods and results Prospective systematic evaluation, on strict adherence to the guidelines, of consecutive patients referred for syncope to the emergency departments of 11 general hospitals. In order to maximize the application, a decision-making guideline-based software was used and trained core medical personnel were designated—both locally in each hospital and centrally—to verify adherence to the diagnostic pathway and give advice on its correction. A diagnostic work-up consistent with the guidelines was completed in 465/541 patients (86%). A definite diagnosis was established in 98% (unexplained in 2%): neurally mediated syncope accounted for 66% of diagnosis, orthostatic hypotension 10%, primary arrhythmias 11%, structural cardiac or cardiopulmonary disease 5%, and non-syncopal attacks 6%, respectively. The initial evaluation (consisting of history, physical examination, and standard electrocardiogram) established a diagnosis in 50% of cases. Hospitalization for the management of syncope was appropriate in 25% and was required for other reasons in a further 13% of cases. The median in-hospital stay was 5.5 days (interquartile range, 3–9). Apart from the initial evaluation, a mean of 1.9±1.1 appropriate tests per patient was performed in 193 patients and led to a final diagnosis in 182 of these (94%). Conclusion The results of this study assess the current standard for the management of syncope on the basis of a rigorous adherence to guidelines of the ESC and provide a frame of reference for daily activity when dealing with syncope.

1 November 2002 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
GBGiorgio Bedogni
Giorgio Bedogni
MMM Malavolti
M Malavolti
SSS Severi
S Severi
MPM Poli
M Poli
CMChiara Mussi
Chiara Mussi
NBN Battistini
N Battistini
Objective: To establish the accuracy of an eight-polar tactile-electrode impedance method in the assessment of total body water (TBW). Design: Transversal study. Setting: University department. Subjects: Fifty healthy subjects (25 men and 25 women) with a mean (s.d.) age of 40 (12) y. Methods: TBW measured by deuterium oxide dilution; resistance (R) of arms, trunk and legs measured at frequencies of 5, 50, 250 and 500 kHz with an eight-polar tactile-electrode impedance-meter (InBody 3.0, Biospace, Seoul, Korea). Results: An algorithm for the prediction of TBW from the whole-body resistance index at 500 kHz (height 2/R500 where R is the sum of the segmental resistances of arms, trunk and legs) was developed in a randomly chosen subsample of 35 subjects. This algorithm had an adjusted coefficient of determination (r2adj) of 0.81 (P<0.0001) and a root mean square error (RMSE) of 3.6 l (9%). Cross-validation of the predictive algorithm in the remaining 15 subjects gave an r2adj of 0.87 (P<0.0001) and an RMSE of 3.0 l (8%). The precision of eight-polar BIA, determined by measuring R three times a day for five consecutive days in a fasting subject, was ≤2.8% for all segments and frequencies. Conclusion: Eight-polar BIA is a precise method that offers accurate estimates of TBW in healthy subjects. This promising method should undergo further studies of precision and its accuracy in assessing extracellular water and appendicular body composition should be determined. Sponsorship: Modena and Reggio Emilia University.

20 April 2018 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
GGGiovanni Guaraldi
Giovanni Guaraldi
AMAndrea Malagoli
Andrea Malagoli
Andrea CalcagnoAndrea Calcagno
Andrea Calcagno
CMChiara Mussi
Chiara Mussi
BCBenedetto Maurizio Celesia
Benedetto Maurizio Celesia
GPG. Di Perri
G. Di Perri
Geriatric Patients Living with HIV/AIDS (GEPPO) is a new prospective observational multicentre cohort consisting of all the HIV-positive geriatric patients being treated at 10 clinics in Italy, and HIV-negative controls attending a single geriatric clinic. The aim of this analysis of the GEPPO cohort was to compare prevalence and risk factors of individual non-communicable diseases (NCD), multi-morbidity (MM) and polypharmacy (PP) amongst HIV positive and HIV negative controls at enrolment into the GEPPO cohort. This cross-sectional study was conducted between June 2015 and May 2016. The duration of HIV infection was subdivided into three intervals: < 10, 10–20 and > 20 years. The NCD diagnoses were based on guidelines defined criteria, including cardiovascular disease, hypertension, type 2 diabetes, chronic kidney disease, dyslipidaemia, chronic obstructive pulmonary disease. MM was classified as the presence of two or more co-morbidities. The medications prescribed for the treatment of comorbidities were collected in both HIV positive and HIV negative group from patient files and were categorized using the Anatomical Therapeutic Chemical (ATC) classification. PP was defined as the presence of five or more drug components other than anti-retroviral agents. The study involved a total of 1573 patient: 1258 HIV positive and 315 HIV negative). The prevalence of individual comorbidities was similar in the two groups with the exception of dyslipidaemia, which was more frequent in the HIV-positive patients (p < 0.01). When the HIV-positive group was stratified based on the duration of HIV infection, most of the co-morbidities were significantly more frequent than in control patients, except for hypertension and cardiovascular disease, while COPD was more prevalent in the control group. MM and PP were both more prevalent in the HIV-positive group, respectively 64% and 37%. MM and PP burden in geriatric HIV positive patients are related to longer duration of HIV-infection rather than older age per se.

11 April 2005 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
ACAndrea Corsonello
Andrea Corsonello
Claudio PedoneClaudio Pedone
Claudio Pedone
FCFrancesco Corica
Francesco Corica
CMChiara Mussi
Chiara Mussi
PCPierugo Carbonin
Pierugo Carbonin
Raffaele Antonelli IncalziRaffaele Antonelli Incalzi
Raffaele Antonelli Incalzi
Adverse drug reactions (ADRs) are important and common causes of hospitalization as well as of in-hospital complications for elderly people.1-4 Age has been shown to be an independent risk factor for ADRs in most but not all the studies, while comorbidity and polypharmacy have been reported to be the main risk factors for ADRs.3-8